United States · FDA National Drug Code directory
OJEMDA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82950-001_8bee41f8-a2d9-44ae-82a9-bd46b6f9916a
- Product NDC
- 82950-001
- Form
- TABLET, FILM COATED
- Composition / generic term
- TOVORAFENIB
- Labeler
- Day One Biopharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20240430
- Source listing expiry
- 20261231
Source-listed ingredients
- TOVORAFENIB — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 BLISTER PACK in 1 CARTON (82950-001-16) / 4 TABLET, FILM COATED in 1 BLISTER PACK (82950-001-04) · 82950-001-16
- 4 BLISTER PACK in 1 CARTON (82950-001-20) / 5 TABLET, FILM COATED in 1 BLISTER PACK (82950-001-05) · 82950-001-20
- 4 BLISTER PACK in 1 CARTON (82950-001-24) / 6 TABLET, FILM COATED in 1 BLISTER PACK (82950-001-06) · 82950-001-24
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →